Loke S L, Stein C A, Zhang X H, Mori K, Nakanishi M, Subasinghe C, Cohen J S, Neckers L M
Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 1989 May;86(10):3474-8. doi: 10.1073/pnas.86.10.3474.
Addition of antisense oligonucleotides to cell cultures has been used to specifically inhibit gene expression. We have investigated the mechanism by which oligonucleotides enter living cells. These compounds are taken up by cells in a saturable, size-dependent manner compatible with receptor-mediated endocytosis. Polynucleotides of any length are competitive inhibitors of oligomer transport, providing they possess a 5'-phosphate moiety. Using oligo(dT)-cellulose for affinity purification, we have identified an 80-kDa surface protein that may mediate transport. Knowledge of the oligonucleotide transport mechanism should facilitate the design of more effective synthetic antisense oligomers as potential clinical agents.
向细胞培养物中添加反义寡核苷酸已被用于特异性抑制基因表达。我们研究了寡核苷酸进入活细胞的机制。这些化合物以与受体介导的内吞作用相适应的可饱和、大小依赖性方式被细胞摄取。任何长度的多核苷酸都是寡聚物转运的竞争性抑制剂,只要它们具有5'-磷酸部分。利用寡聚(dT)-纤维素进行亲和纯化,我们鉴定出一种可能介导转运的80 kDa表面蛋白。了解寡核苷酸转运机制应有助于设计更有效的合成反义寡聚物作为潜在的临床药物。